Afatinib CAS 439081-18-2 Mama>99.5% (HPLC) Falegaosimea
Ruifu Sapalai Vailaau Fa'alava ole Afatinib
Afatinib CAS 439081-18-2
Afatinib Dimaleate CAS 850140-73-7
(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2
(Dimethylamino)acetaldehyde Diethyl Acetal CAS 3616-56-6
trans-4-Dimethylaminocrotonic Acid Hydrochloride CAS 848133-35-7
Diethylphosphonoacetic Acid CAS 3095-95-2
7-Fluoro-6-Nitroquinazolin-4(1H)-tasi CAS 162012-69-3
7-Chloro-6-Nitro-4-Hydroxyquinazoline CAS 53449-14-2
N-(3-Chloro-4-Fluorophenyl)-7-Fluoro-6-Nitroquinazolin-4-Amine CAS 162012-67-1
(S)-N4-(3-Chloro-4-Fluorophenyl)-7-((Tetrahydrofuran-3-yl) oxy)quinazoline-4,6-DiamineCAS 314771-76-1
(S)-N-(3-Chloro-4-Fluorophenyl)-6-Nitro-7-((Tetrahydrofuran-3-yl) oxy)quinazolin-4-AmineCAS 314771-88-5
Igoa Vailaau | Afatinib |
Synonyms | BIBW2992;BIBW-2992;BIBW2992 Fa'avae Sa'oloto;Tomtovok;(S,E)-N-(4-(3-Chloro-4-Fluorophenylamino)-7-(Tetrahydrofuran-3-yloxy)quinazolin-6-yl)-4-(Dimethylamino)ae-2-Enamide |
Numera CAS | 439081-18-2 |
CAT Numera | RF-PI2033 |
Tulaga Fa'asoa | I Fa'atauga, Oloa Fua e O'o i Tone |
Fuafua mole | C24H25ClFN5O3 |
Molecular Weight | 485.94 |
Solubility | Solu i le DMSO |
Malosi | 1.380 |
Fa'ailoga | Ruifu Chemical |
Aitema | Fa'amatalaga |
Fa'aaliga | Pa'u Pa'epa'e Pa'epa'e |
Fa'ailoaga | HPLC, NMR |
Mama / Suʻesuʻega Metotia | >99.5% (HPLC) |
Lisi Lisi | 100.0~102.0 ℃ |
Ma'imau ile Fa'amago | <0.50% |
Toega i luga o le mumu | <0.20% |
Aofa'i Fa'aleaga | <0.50% |
Metala mamafa | ≤20ppm |
NMR Alaleo | E tusa ma le Fauga |
Tulaga Su'ega | Pisinisi Tulaga |
Ola Fa'asa | 24 masina pe a teu lelei |
Fa'aoga | API;Afatinib;Afatinib Dimaleate;NSCLC |
afifi: Fagu, ato pepa alumini, 25kg/Kati Pusa, pe tusa ai ma manaoga o tagata faatau
Tulaga teuina:Teu i totonu o pusa faʻamaufaʻailoga i se nofoaga malulu ma mago;Puipui mai le malamalama ma le susu
Afatinib, lea e lauiloa foi o le BIW-2992, (CAS: 439081-18-2) o le lona lua-tupulaga malosi ma le le mafai ona toe faʻafoʻiina o le inhibitor lua o le epidermal growth factor receptor (EGFR) ma le tagata epidermal growth factor receptor 2 (HER2) tyrosine kinase, fausia e Boehringer Ingelheim, Siamani.E mafai ona faʻalavelaveina le gaioiga o le tyrosine kinase e ala i le faia o le tali a Michael ma le vaega thiol o le cysteine i le tulaga 797 o le EGFR.I le aso 12 o Iulai, 2013, na avea ai ma vailaʻau fou mo le kanesa o le mama sela laiti na faʻamaonia e le US FDA i lalo o le igoa tau fefaʻatauaʻiga o Gilotrif.O lenei vailaʻau o se laulau.E faʻaaogaina mo togafitiga o tagata mamaʻi na maua i le metastatic non-small cell lung cancer (NSCLC) faʻatasi ai ma le leiloa o le 19th exon poʻo le L858R mutation i le 21th exon o le tumor epidermal growth factor receptor (EGFR) faʻamaonia i le faʻaaogaina o le pusa faʻamaonia. e le FDA.E aoga foi le vaila'au i le togafitia o tagata mama'i HER2-lelei ma le kanesa o le susu.Afatinib e aofia i se vasega o vailaʻau e taʻua o tyrosine kinase inhibitors.Tyrosine kinase inhibitors ua mamanuina e poloka ai le gaioiga a se enzyme patino e taʻua o tyrosine kinase.O lenei enzyme e tele sona sao i le gaioiga o sela, ma e malosi i le faʻalauiloaina o le tuputupu aʻe ma le alualu i luma.Afatinib e galue e faʻalavelaveina le gaioiga o ituaiga e lua o tyrosine kinases: epidermal growth factor receptor (EGFR) ma Her2, lea e "faʻaalia" e le tele o ituaiga o kanesa.E ala i le polokaina o galuega a nei tyrosine kinases, e mafai e Afatinib ona taofia sela o le kanesa mai le vaeluaina ma le tuputupu aʻe.